Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 12:12:100348.
doi: 10.1016/j.rcsop.2023.100348. eCollection 2023 Dec.

Drug-related problems in hospitalized patients with type 2 diabetes mellitus: A systematic review

Mohammad Hisyamuddin Awang Jihadi  1 , Ana Yuda  2 , Anila Impian Sukorini  2 , Andi Hermansyah  2 , Naeem Shafqat  1 , Ching Siang Tan  3 , Long Chiau Ming  1   2   4
Affiliations
Review

Drug-related problems in hospitalized patients with type 2 diabetes mellitus: A systematic review

Mohammad Hisyamuddin Awang Jihadi et al. Explor Res Clin Soc Pharm. .

Abstract

Introduction: Type 2 diabetes mellitus (T2DM) is one of the non-communicable diseases which continues to rise in prevalence and mortality rate throughout the years. Drug-related problems (DRPs) are more prevalent among T2DM patients especially those with co-morbidities.

Objective: The objective of this study was to review and assess the prevalence and characteristics of DRPs among hospitalized type 2 diabetes mellitus patients.

Methods: The systematic review of the literature was carried out using five online databases: PubMed, Scopus, Google Scholar, Web of Science, and Cochrane Library from the inception of the database until June 2022. Studies included in the review were published in English or Malay language. The data were extracted and assessed using the Joanna Briggs Institute (JBI) critical appraisal tools.

Results: A total of 939 studies were identified with 20 studies that met inclusion criteria and were included in this systematic review. The overall prevalence of DRPs in all 20 studies ranged from 7% to 94%. The most common DRPs included drug-drug interaction (DDI), adverse drug reaction (ADR), therapeutic effectiveness problems, and inappropriate medication use.

Conclusion: The most common drug classes involved were antidiabetics (metformin), antihypertensives, antiplatelets and antibiotics. The risk factors contributing to DRPs included the presence of comorbidities, the number of medications, and polypharmacy. To conclude, the rate of DRPs incidence in hospitalized T2DM patients was observed to be high. Further future studies with appropriate study designs and methods of detecting DRPs will be necessary to reduce and prevent DRPs occurrences.

Keywords: Adverse drug reaction; Diabetes; Drug safety; Health care quality; Health outcomes; Medical care; Patient safety; Pharmaceutical care.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
PRISMA flow chart.
See this image and copyright information in PMC

References

    1. Pharmaceutical Care Network Europe Association Pharmaceutial Care Network Europe (PCNE) Classification for drug-related problems V9. 1. 2020. https://www.pcne.org/upload/files/417_PCNE_classification_V9-1_final.pdf Available online. Accessed 12 Aug 2023.
    1. Salmasi S., Wimmer B.C., Khan T.M., Zaidi S.T.R., Ming L.C. A proposed stepwise approach to reducing medication errors in older people. Res Soc Adm Pharm. 2018;14(2):207–209. - PubMed
    1. Xue Qin Q.N., Ming L.C., Abd Wahab M.S., Tan C.S., Yuda A., Hermansyah A. Drug-related problems among older people with dementia: a systematic review. Res Soc Adm Pharm. 2023;19(6):873–881. - PubMed
    1. van den Bemt P.M., Egberts T.C., de Jong-van den Berg LT, Brouwers J.R. Drug-related problems in hospitalised patients. Drug Saf. 2000;22(4):321–333. - PubMed
    1. Aronson J.K., Ferner R.E. Clarification of terminology in drug safety. Drug Saf. 2005;28(10):851–870. - PubMed